Liposome-based delivery of biological drugs

被引:120
作者
Magar, Kosheli Thapa [1 ]
Boafo, George Frimpong [1 ]
Li, Xiaotong [1 ]
Chen, Zhongjian [2 ]
He, Wei [1 ,2 ]
机构
[1] China Pharmaceut Univ, Sch Pharm, Dept Pharmaceut, Nanjing 211198, Peoples R China
[2] Tongji Univ, Shanghai Skin Dis Hosp, Sch Med, Shanghai 200443, Peoples R China
基金
中国国家自然科学基金;
关键词
Liposomes; Drug delivery; Biological drugs; Endocytosis; Toxicity; INSULIN-LOADED LIPOSOMES; IN-VIVO; TRANSFECTION EFFICIENCY; PEGYLATED LIPOSOMES; IMMUNE-RESPONSES; CATIONIC LIPIDS; BILE-SALTS; ANTIBODY; VACCINE; NANOPARTICLES;
D O I
10.1016/j.cclet.2021.08.020
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Biological drugs are attracting tremendous attention in disease treatment. However, their application is significantly limited by their inherent properties, such as high hydrophilicity, poor membrane-permeability, low stability, and larger size. Liposome-based drug delivery systems are emerging as promising tools to improve their delivery, owing to their ability to reduce toxicity, improve bioavailability, and enhance the therapeutic efficacy of the drug by optimizing delivery to the specific target site. Here, we reviewed the types of liposomes and their applications as carriers for biological drugs to treat various diseases, emphasized the commercial products, and ultimately provided perspectives in this field. (C) 2021 Published by Elsevier B.V. on behalf of Chinese Chemical Society and Institute of Materia Medica, Chinese Academy of Medical Sciences.
引用
收藏
页码:587 / 596
页数:10
相关论文
共 138 条
[1]  
Abu Lila AS, 2017, BIOL PHARM BULL, V40, P1, DOI 10.1248/bpb.b16-00624
[2]  
Alam Masroor, 2005, Pain Pract, V5, P349, DOI 10.1111/j.1533-2500.2005.00048.x
[3]   Lipoproteins-Nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects [J].
Alanazi, Saleh A. ;
Alanazi, Fars ;
Haq, Nazrul ;
Shakeel, Faiyaz ;
Badran, Mohamed M. ;
Harisa, Gamaleldin, I .
CURRENT DRUG DELIVERY, 2020, 17 (10) :826-844
[4]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[5]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[6]  
Alves NJ, 2015, THER DELIV, V6, P873, DOI [10.4155/TDE.15.40, 10.4155/tde.15.40]
[7]   Rational design of adjuvants for subunit vaccines: The format of cationic adjuvants affects the induction of antigen-specific antibody responses [J].
Anderluzzi, Giulia ;
Schmidt, Signe Tandrup ;
Cunliffe, Robert ;
Woods, Stuart ;
Roberts, Craig W. ;
Veggi, Daniele ;
Ferlenghi, Ilaria ;
O'Hagan, Derek T. ;
Baudner, Barbara C. ;
Perrie, Yvonne .
JOURNAL OF CONTROLLED RELEASE, 2021, 330 :933-944
[8]   Dynamic Interactions between Lipid-Tethered DNA and Phospholipid Membranes [J].
Arnott, Patrick M. ;
Joshi, Himanshu ;
Aksimentiev, Aleksei ;
Howorka, Stefan .
LANGMUIR, 2018, 34 (49) :15084-15092
[9]   Endocytic Pathway and Resistance to Cholesterol Depletion of Cholesterol Derived Cationic Lipids for Gene Delivery [J].
Bae, Yun-Ui ;
Kim, Bieong-Kil ;
Park, Jong-Won ;
Seu, Young-Bae ;
Doh, Kyung-Oh .
MOLECULAR PHARMACEUTICS, 2012, 9 (12) :3579-3585
[10]  
Bangham A.D., 1980, LIPOSOMES BIOL SYST, P7